Claim and evidence Close ×
The Hong Kong prospectus of QuantumPharm Inc. (renamed XtalPi Holdings Limited with effect from 8 November 2024), dated 4 June 2024, states that the company is a Specialist Technology Company and a Pre-Commercial Company as defined in Chapter 18C of the Hong Kong Listing Rules. Copy claim link
Copy claim reference
Machine-checked, not reviewed by an editor Stated in source Supported
Supporting evidence: primary · 1 source; Context: primary · 1 source
Provision Statement · provision ID co-xtalpi-18c-2024 Date 2024-06-04 · publication Records dated 2024 → Scope and limits The issuer's statement of its listing basis. XtalPi's about page (served 2026-10-30) describes its listing as "18C 第一股" (Selekoa's translation: "the first 18C stock"); that ordinal is the company's, not verified here against HKEX records.
The evidence 03 primary source Supports the claim
QuantumPharm Inc. Global Offering (Hong Kong prospectus) ↗ QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews · 2024-06-04
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “Our Company is a Specialist Technology Company (as defined in Chapter 18C of the Listing Rules).” Location in source Cover pages (PDF p. 2)
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews Version Retrieved for the candidate pack on 2026-10-30 (SHA-256 fce5a6aee28817f6b479cf259cfe75d65f48b1519f6173f21cf183bb767a93df). HKEXnews PDF 2024060400065, English prospectus dated June 4, 2024, as served on 2026-10-30. Canonical address Open the canonical source ↗ Accessed 2026-10-30 Language English (en) Attribution QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews, “QuantumPharm Inc. Global Offering (Hong Kong prospectus)”, 2024-06-04. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (16 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review. primary source Supports the claim
QuantumPharm Inc. Global Offering (Hong Kong prospectus) ↗ QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews · 2024-06-04
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “our Company is a Pre-Commercial Company (as defined in Chapter 18C of the Listing Rules).” Location in source Cover pages (PDF p. 2)
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews Version Retrieved for the candidate pack on 2026-10-30 (SHA-256 fce5a6aee28817f6b479cf259cfe75d65f48b1519f6173f21cf183bb767a93df). HKEXnews PDF 2024060400065, English prospectus dated June 4, 2024, as served on 2026-10-30. Canonical address Open the canonical source ↗ Accessed 2026-10-30 Language English (en) Attribution QuantumPharm Inc. (now XtalPi Holdings Limited), published on HKEXnews, “QuantumPharm Inc. Global Offering (Hong Kong prospectus)”, 2024-06-04. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (15 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. No human editorial review. primary source Context only
关于我们 | 晶泰科技 XtalPi ↗ XtalPi (晶泰科技) · Publication date unknown · In Simplified Chinese (zh-Hans)
Copy source reference
Cite the original source Cite the original document, not Selekoa. Check these details against it.
Copy APA
Download BibTeX Download RIS Download CSL-JSON
Source excerpt “作为 18C 第一股在香港证券交易所成功上市” Location in source 发展历程 (timeline), 2024
How it was read Retrieved directly from the publisher
Machine-checked · 2026-10-30
Source details and check notes Authors XtalPi (晶泰科技) Version Retrieved for the candidate pack on 2026-10-30 (SHA-256 c9437e9a1e39b0b33e4fe047e8f1eac9db322620a6655b689461428836684458). xtalpi.com/zh/about/ (served at /about/), Chinese-language page, as served on 2026-10-30 (the page states no date of its own). Its wording can change; earlier wording is not authenticated. Canonical address Open the canonical source ↗ Accessed 2026-10-30 Language Simplified Chinese (zh-Hans) Attribution XtalPi (晶泰科技), “关于我们 | 晶泰科技 XtalPi”. Reuse No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution. Check notes Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (18 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. English machine translation, not verified by a person: “successfully listed on the Hong Kong Stock Exchange as the first 18C stock”. The company's own ordinal claim, kept as context. No human editorial review. Status and meaning Editorial status. Not reviewed by an editor . An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.
Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.
Date. Prospectus date.
Record ID aib-co-xtalpi-18c-2024